Evidence map›Paper›PMID 39904947›Full record

ArticleESC heart failure2025

Prognostic impact of gait speed, muscle strength and muscle mass in chronic heart failure-A prospective cohort study.

Vladimir Cejka, Hermann Riepl, Nora Schwegel, Ewald Kolesnik, David Zach, Viktoria Santner, Viktoria Höller, Natascha Schweighofer, Barbara Obermayer-Pietsch, Thomas Pieber and 8 more

Abstract read
In one paragraph

Article in ESC heart failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Vladimir CejkaDepartment of Clinical Research and Epidemiology, Comprehensive Heart Failure Center, University Hospital Würzburg, Würzburg, Germany.
Hermann RieplDivision of Cardiology, Department of Internal Medicine, University Heart Center, Medical University of Graz, Graz, Austria.
Nora SchwegelDivision of Cardiology, Department of Internal Medicine, University Heart Center, Medical University of Graz, Graz, Austria.
Ewald KolesnikDivision of Cardiology, Department of Internal Medicine, University Heart Center, Medical University of Graz, Graz, Austria.
David ZachDivision of Cardiology, Department of Internal Medicine, University Heart Center, Medical University of Graz, Graz, Austria.
Viktoria SantnerDivision of Cardiology, Department of Internal Medicine, University Heart Center, Medical University of Graz, Graz, Austria.
Viktoria HöllerDivision of Cardiology, Department of Internal Medicine, University Heart Center, Medical University of Graz, Graz, Austria.
Natascha SchweighoferDivision of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Barbara Obermayer-PietschDivision of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Thomas PieberDivision of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Caroline MorbachDepartment of Clinical Research and Epidemiology, Comprehensive Heart Failure Center, University Hospital Würzburg, Würzburg, Germany.
Stefan FrantzDepartment of Clinical Research and Epidemiology, Comprehensive Heart Failure Center, University Hospital Würzburg, Würzburg, Germany.
Andreas ZirlikDivision of Cardiology, Department of Internal Medicine, University Heart Center, Medical University of Graz, Graz, Austria.
Dirk von LewinskiDivision of Cardiology, Department of Internal Medicine, University Heart Center, Medical University of Graz, Graz, Austria.
Stefan StörkDepartment of Clinical Research and Epidemiology, Comprehensive Heart Failure Center, University Hospital Würzburg, Würzburg, Germany.
Florian PoschDivision of Hematology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Klemens AblasserDivision of Cardiology, Department of Internal Medicine, University Heart Center, Medical University of Graz, Graz, Austria.
Nicolas VerheyenDivision of Cardiology, Department of Internal Medicine, University Heart Center, Medical University of Graz, Graz, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsHeart failure (HF) impairs skeletal muscle mass and function, which contributes to reduced physical performance. We investigated the prognostic impact of gait speed (GS), handgrip strength (HG) and appendicular skeletal muscle index (ASMI) on cardiovascular outcomes in a prospective HF cohort.

methodsThis single-centre prospective cohort study included adults with stable chronic HF with a previous diagnosis of overtly reduced left ventricular ejection fraction (LVEF) <40% and LVEF < 50% at enrolment. GS was measured by the 4 m GS test, maximal HG was measured with a hydraulic dynamometer, and ASMI was measured by dual-energy X-ray absorptiometry. The primary combined outcome was cardiovascular death or worsening HF. Fine and Gray regression models were calculated, treating non-cardiovascular death as the competing event.

resultsTwo hundred five patients (78% male) were analysed. The median age was 66 (quartiles: 58-74) years, 31% had diabetes mellitus, and the median LVEF was 37 (30-43) %. Median GS was 1.0 (0.8-1.0) m/s, median HG was 32 (24-40) kg, and median ASMI was 8.0 (7.2-8.9) kg/m

conclusionsHigher GS was independently associated with a lower risk of cardiovascular death or worsening HF, whereas HG and ASMI were not. We prospectively confirm GS as a physical performance measure with clear prognostic significance for patients with HF.

Indexed as

Hand StrengthHeart FailureMuscle, SkeletalMuscle StrengthStroke VolumeVentricular Function, LeftWalking SpeedAgedChronic DiseaseFemaleFollow-Up StudiesHumansMaleMiddle AgedPrognosisProspective StudiesASMIcardiovascular outcomegait speedhandgripheart failureprognostic impact

Identifiers

PMID39904947
PMCPMC12055347

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.